Tet-offシステムを利用したGAD67ノックダウンマウスの開発と表現型解析

• Published in: 日本薬理学会年会要旨集 p. 1-P-004
• Main Authors: 崎村, 建司, 平野, 瞳子, 中井, 淳一, 田中, 謙二, 阿部, 学, 柳川, 右千夫, 藤原, 和之, 宮田, 茂雄, 柿崎, 利和, 渡辺, 雅彦, 大日方, 英
• Format: Journal Article
• Language: Japanese
• Published: 公益社団法人 日本薬理学会 2020
• Subjects: behavior; gamma-aminobutyric acid (GABA); transgenic animal
• ISSN: 2435-4953
• DOI: 10.1254/jpssuppl.93.0_1-P-004

GABA is a major inhibitory neurotransmitter in the mammalian brain and regulates emotional behaviors. GABA is synthesized from glutamate by glutamate decarboxylase (GAD) which exists as two isoforms, GAD65 and GAD67, encoded by separate genes. The function of GAD65 is well investigated by using global GAD65 knockout (GAD65-/-) mice. However, the function of GAD67, particularly in the adult brain, is not well investigated because GAD67-/- mice died on the day of the birth. In order to resolve the function of GAD67, we developed novel GAD67 knockdown (GAD67tTA/STOP-tetO) mice by using a Tet-off system and investigated the biological phenotypes in those mice. Approximately 30% of GAD67tTA/STOP-tetO mice survived to adulthood. Treatment with doxycycline (Dox) for 3 weeks in adulthood markedly decreased the protein levels of GAD67 in the frontal cortex, hippocampus and cerebellum of GAD67tTA/STOP-tetO mice. Metabolome analysis demonstrated that the GABA contents were significantly decreased in the frontal cortex, hippocampus and cerebellum of Dox-treated GAD67tTA/STOP-tetO mice compared to Dox-treated GAD67+/+ mice. In addition, several other metabolites were significantly decreased in the frontal cortex, but not in the hippocampus or cerebellum, of Dox-treated GAD67tTA/STOP-tetO mice. On the other hand, no significant difference was observed in the metabolite levels, including GABA content, in the frontal cortex between GAD65-/- and GAD65+/+ mice. These results suggest that GAD67 is the major enzyme of GABA synthesis and regulates metabolite levels in a brain region-dependent manner.